Stay updated on Elafibranor in NASH: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.

Latest updates to the Elafibranor in NASH: Efficacy & Safety Clinical Trial page
- Check2 days agoChange DetectedThe page's text remains unchanged. There are no additions or deletions to report.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded the U.S. NIH grant/contract identifier under Other Study ID Numbers to clarify funding provenance for the study. Updated the page revision to v3.6.6, replacing the previous v3.6.5 entry to reflect a new version of the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's revision metadata was updated from v3.6.4 to v3.6.5, indicating a minor update to the page's versioning. The substantive content and study details remain unchanged.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4. This appears to be a small software update with no changes to content or visible features.SummaryDifference0.0%

- Check52 days agoChange DetectedThe glossary/MeSH term Fatty Liver Disease has been updated to Steatotic Liver Disease. This change aligns terminology with current classifications and affects indexing rather than the study data.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a small software update applied to the page rendering.SummaryDifference0.0%

Stay in the know with updates to Elafibranor in NASH: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.